Skip to main content

The Crohn’s Disease Activity Index as a Clinical Instrument

  • Chapter
Recent Advances in Crohn’s Disease

Part of the book series: Developments in Gastroenterology ((DIGA,volume 1))

Abstract

Attempts to quantify clinical activity of Crohn’s disease [CD] are made difficult by the facts that it is a disease of unknown etiology and that its manifestations are nonspecific. In planning the National Cooperative Crohn’s Disease Studies [NCCDS], it was apparent that some composite index of disease activity would be useful to classify initial states, to identify worsening sufficient to mandate removal from study, to quantify clinical response, and to regulate corticosteroid dosage.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Best WR, Becktel JM, Singleton JW, Kern F.Jr. (1976) Development of a Crohn’s Disease Activity Index. Gastroenterology 70:439–444

    PubMed  CAS  Google Scholar 

  2. Winship DH, Summers RW, Singleton JW, Best WR, Becktel JM, Lenk LF, Kern F.Jr. (1979 ) National Cooperative Crohn’s Disease Study: Study Design and Conduct of Study. Gastroenterology 77:829–842

    PubMed  CAS  Google Scholar 

  3. Summers RW, Switz DM, Sessions JT.Jr. Becktel JM, Best WR, Kern F.Jr., Singleton JW. (1979) National Cooperative Crohn’s Disease Study: Results of Drug Treatment. Gastroenterology 77:847–869

    PubMed  CAS  Google Scholar 

  4. Singleton JW, Summers RW, Kern F.Jr., Becktel JM, Best WR, Hansen RN, Winship DH. (1979) A trial of Sulfasalazine as Adjunctive Therapy in Crohn’s Disease. Gastroenterology 77:887–897

    PubMed  CAS  Google Scholar 

  5. Best WR, Becktel JM, Singleton JW. (1979) Rederived Values of the Eight Coefficients of the Crohn’s Disease Activity Index (CDAI). Gastroenterology 77:843–846

    PubMed  CAS  Google Scholar 

  6. Kaufman S, Chalmer B, Heilman R, Beeken W. (1979) A prospective study of the course of Crohn’s Disease. Am. J. Digest.Dis. 24:269–276

    Article  CAS  Google Scholar 

  7. Vantrappen G, Ghoos Y, Rutgeerts P, Janssens J. (1977) Bile acid studies in uncomplicated Crohn’s disease. Gut 18:730–735

    Article  PubMed  CAS  Google Scholar 

  8. Mee AS, Brown DJ, Jewell DP. (1978) Crohn’s Disease activity index — is it useful? Gut 19:A990

    Google Scholar 

  9. Descos L, Andre C, Beorchia S, Vincent C, Revillard JP. (1979) Serum levels of 2-microglobulin—a new marker of activity in Crohn’s disease. New.Engl.J.Med. 301:441–442

    Article  Google Scholar 

  10. Fiasse R, Lurhama AZ, Cambiaso CL, Masson PL, Dive C. (1978) Circulating immune complexes and disease activity in Crohn’s disease. Gut 19:611–617

    Article  PubMed  CAS  Google Scholar 

  11. Solomons NW, Elson CO, Pekarek RS, Jacob RA, Sandstead HH, Rosenberg IH. (1978) Leukocytic endogenous mediator in Crohn’s disease. Infect.Immun. 22:637–639

    PubMed  CAS  Google Scholar 

  12. Colin R, Grancher T, Lemeland JF, Hecketsweiler P, Galmiche JP, LeGrix A, Geffroy Y. (1979) Recherche d’une endotoxinemie dans les entero-colitis inflammatoires cryptogenetiques. Gastroenterol.Clin.Biol. 3:15–19

    PubMed  CAS  Google Scholar 

  13. Smith RC, Rhodes Jf Heatley RV, Hughes LE, Crosby DL, Rees BI, Jones H, Evans KT, Lawrie BW. (1978) Low dose steroids and clinical relapse in Crohn’s disease; a controlled trial. Gut 19:606–610

    Article  PubMed  CAS  Google Scholar 

  14. Keighley MRB, Arabi Y, Dimock F, Burdon DW, Allan RN, Alexander-Williams J. (1978) Influence of inflammatory bowel disease on intestinal microflora. Gut 19:1099–1104

    Article  PubMed  CAS  Google Scholar 

  15. Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, Pasternack BS. (1980) Treatment of Crohn’s Disease with 6-mercaptopurine. New Engl.J.Med. 302:981–987

    Article  PubMed  CAS  Google Scholar 

  16. Vicary FR, Chambers JD, Dhillon P. (1979) Double-blind trial of the use of transfer factor in the treatment of Crohn’s Disease. Gut 20:408–413

    Article  PubMed  CAS  Google Scholar 

  17. Hecketsweiler P, Bernier JJ, Geffroy Y. (1979) Les Essais therapeutiques au cours de la Maladie de Crohn et de la Rectocolite Hemorragique; Ethique, objectifs, methodologie. Une etude cooperative du G.R.E.C. Gastroenterol. Clin.Biol. 3:67–72

    PubMed  CAS  Google Scholar 

  18. Harvey RF, Bradshaw JM. (1980) A simple index of Crohn’s Disease activity. Lancet 1:514

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Martinus Nijhoff Publishers bv, The Hague

About this chapter

Cite this chapter

Best, W.R., Becktel, J.M. (1981). The Crohn’s Disease Activity Index as a Clinical Instrument. In: Peña, A.S., Weterman, I.T., Booth, C.C., Strober, W. (eds) Recent Advances in Crohn’s Disease. Developments in Gastroenterology, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-8273-4_2

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-8273-4_2

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-8275-8

  • Online ISBN: 978-94-009-8273-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics